The Use of Polymer Blends in the Treatment of Ocular Diseases

The eye is an organ with limited drug access due to its anatomical and physiological barriers, and the usual forms of ocular administration are limited in terms of drug penetration, residence time, and bioavailability, as well as low patient compliance. Hence, therapeutic innovations in new drug del...

Full description

Bibliographic Details
Main Authors: Raquel Gregorio Arribada, Francine Behar-Cohen, Andre Luis Branco de Barros, Armando Silva-Cunha
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/7/1431
_version_ 1797444369952800768
author Raquel Gregorio Arribada
Francine Behar-Cohen
Andre Luis Branco de Barros
Armando Silva-Cunha
author_facet Raquel Gregorio Arribada
Francine Behar-Cohen
Andre Luis Branco de Barros
Armando Silva-Cunha
author_sort Raquel Gregorio Arribada
collection DOAJ
description The eye is an organ with limited drug access due to its anatomical and physiological barriers, and the usual forms of ocular administration are limited in terms of drug penetration, residence time, and bioavailability, as well as low patient compliance. Hence, therapeutic innovations in new drug delivery systems (DDS) have been widely explored since they show numerous advantages over conventional methods, besides delivering the content to the eye without interfering with its normal functioning. Polymers are usually used in DDS and many of them are applicable to ophthalmic use, especially biodegradable ones. Even so, it can be a hard task to find a singular polymer with all the desirable properties to deliver the best performance, and combining two or more polymers in a blend has proven to be more convenient, efficient, and cost-effective. This review was carried out to assess the use of polymer blends as DDS. The search conducted in the databases of Pubmed and Scopus for specific terms revealed that although the physical combination of polymers is largely applied, the term polymer blend still has low compliance.
first_indexed 2024-03-09T13:10:42Z
format Article
id doaj.art-82b7249988624926a02ef3b99efe486b
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T13:10:42Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-82b7249988624926a02ef3b99efe486b2023-11-30T21:41:59ZengMDPI AGPharmaceutics1999-49232022-07-01147143110.3390/pharmaceutics14071431The Use of Polymer Blends in the Treatment of Ocular DiseasesRaquel Gregorio Arribada0Francine Behar-Cohen1Andre Luis Branco de Barros2Armando Silva-Cunha3Laboratory of Pharmacotechnics and Pharmaceutical Technology, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte 31270-901, BrazilInserm UMR_S 1138, Team 17, Physiopathology of Ocular Diseases: Therapeutic Innovations at Centre de Recherche des Cordeliers, 75006 Paris, FranceLaboratory of Pharmacotechnics and Pharmaceutical Technology, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte 31270-901, BrazilLaboratory of Pharmacotechnics and Pharmaceutical Technology, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte 31270-901, BrazilThe eye is an organ with limited drug access due to its anatomical and physiological barriers, and the usual forms of ocular administration are limited in terms of drug penetration, residence time, and bioavailability, as well as low patient compliance. Hence, therapeutic innovations in new drug delivery systems (DDS) have been widely explored since they show numerous advantages over conventional methods, besides delivering the content to the eye without interfering with its normal functioning. Polymers are usually used in DDS and many of them are applicable to ophthalmic use, especially biodegradable ones. Even so, it can be a hard task to find a singular polymer with all the desirable properties to deliver the best performance, and combining two or more polymers in a blend has proven to be more convenient, efficient, and cost-effective. This review was carried out to assess the use of polymer blends as DDS. The search conducted in the databases of Pubmed and Scopus for specific terms revealed that although the physical combination of polymers is largely applied, the term polymer blend still has low compliance.https://www.mdpi.com/1999-4923/14/7/1431polymer blendbiopolymersophthalmic administrationdrug delivery systempolymer associationocular use
spellingShingle Raquel Gregorio Arribada
Francine Behar-Cohen
Andre Luis Branco de Barros
Armando Silva-Cunha
The Use of Polymer Blends in the Treatment of Ocular Diseases
Pharmaceutics
polymer blend
biopolymers
ophthalmic administration
drug delivery system
polymer association
ocular use
title The Use of Polymer Blends in the Treatment of Ocular Diseases
title_full The Use of Polymer Blends in the Treatment of Ocular Diseases
title_fullStr The Use of Polymer Blends in the Treatment of Ocular Diseases
title_full_unstemmed The Use of Polymer Blends in the Treatment of Ocular Diseases
title_short The Use of Polymer Blends in the Treatment of Ocular Diseases
title_sort use of polymer blends in the treatment of ocular diseases
topic polymer blend
biopolymers
ophthalmic administration
drug delivery system
polymer association
ocular use
url https://www.mdpi.com/1999-4923/14/7/1431
work_keys_str_mv AT raquelgregorioarribada theuseofpolymerblendsinthetreatmentofoculardiseases
AT francinebeharcohen theuseofpolymerblendsinthetreatmentofoculardiseases
AT andreluisbrancodebarros theuseofpolymerblendsinthetreatmentofoculardiseases
AT armandosilvacunha theuseofpolymerblendsinthetreatmentofoculardiseases
AT raquelgregorioarribada useofpolymerblendsinthetreatmentofoculardiseases
AT francinebeharcohen useofpolymerblendsinthetreatmentofoculardiseases
AT andreluisbrancodebarros useofpolymerblendsinthetreatmentofoculardiseases
AT armandosilvacunha useofpolymerblendsinthetreatmentofoculardiseases